Title |
Rationale, design and organization of the delayed antibiotic prescription (DAP) trial: a randomized controlled trial of the efficacy and safety of delayed antibiotic prescribing strategies in the non-complicated acute respiratory tract infections in general practice
|
---|---|
Published in |
BMC Primary Care, May 2013
|
DOI | 10.1186/1471-2296-14-63 |
Pubmed ID | |
Authors |
Mariam de la Poza Abad, Gemma Mas Dalmau, Mikel Moreno Bakedano, Ana Isabel González González, Yolanda Canellas Criado, Silvia Hernández Anadón, Rafael Rotaeche del Campo, Pere Torán Monserrat, Antonio Negrete Palma, Guillem Pera, Eulàlia Borrell Thió, Carl LLor, Paul Little, Pablo Alonso Coello, for the Delayed Antibiotic Prescription (DAP) Working Group |
Abstract |
Respiratory tract infections are an important burden in primary care and it's known that they are usually self-limited and that antibiotics only alter its course slightly. This together with the alarming increase of bacterial resistance due to increased use of antimicrobials calls for a need to consider strategies to reduce their use. One of these strategies is the delayed prescription of antibiotics. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 4 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 3% |
Spain | 2 | 3% |
Brazil | 1 | 1% |
Unknown | 69 | 93% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 13 | 18% |
Student > Ph. D. Student | 9 | 12% |
Student > Bachelor | 8 | 11% |
Professor > Associate Professor | 7 | 9% |
Student > Master | 7 | 9% |
Other | 13 | 18% |
Unknown | 17 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 28 | 38% |
Nursing and Health Professions | 7 | 9% |
Business, Management and Accounting | 4 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
Social Sciences | 3 | 4% |
Other | 9 | 12% |
Unknown | 20 | 27% |